97 related articles for article (PubMed ID: 29630088)
1. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
[TBL] [Abstract][Full Text] [Related]
2. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases.
Bülbül Doğusoy G;
Turk J Gastroenterol; 2012 Jun; 23(3):203-11. PubMed ID: 22798108
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
5. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
6. Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry.
Şahin S; Ekinci O; Seçkin S; Dursun A
Pathol Res Pract; 2017 Sep; 213(9):1139-1143. PubMed ID: 28756979
[TBL] [Abstract][Full Text] [Related]
7. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biologic potential and risk stratification for predicting disease-free survival after resection of primary gastrointestinal stromal tumor: A multivariate clinicopathological study.
Vij M; Agrawal V; Kumar A; Pandey R
Indian J Cancer; 2015; 52(3):351-7. PubMed ID: 26905135
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 121 cases.
Vij M; Agrawal V; Kumar A; Pandey R
Indian J Gastroenterol; 2010 Nov; 29(6):231-6. PubMed ID: 21221881
[TBL] [Abstract][Full Text] [Related]
11. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV
Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.
Ozgüç H; Yilmazlar T; Yerci O; Soylu R; Tümay V; Filiz G; Zorluoglu A
J Gastrointest Surg; 2005 Mar; 9(3):418-29. PubMed ID: 15749606
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours.
Yamamoto H; Handa M; Tobo T; Setsu N; Fujita K; Oshiro Y; Mihara Y; Yoshikawa Y; Oda Y
Histopathology; 2013 Aug; 63(2):194-207. PubMed ID: 23763337
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
16. [Stromal gastrointestinal tumors: retrospective study of 24 cases].
Boudabous H; Chaker Y; Nouira R; Dziri C
Tunis Med; 2013 Nov; 91(11):661-7. PubMed ID: 24343490
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
18. [A clinicopathologic and immunohistochemical study on 76 cases of gastrointestinal stromal tumors].
Hou Y; Wang J; Zhu X; Du X; Sun M; Zheng A
Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):20-5. PubMed ID: 11955330
[TBL] [Abstract][Full Text] [Related]
19. Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysis.
Perez D; Demartines N; Meier K; Clavien PA; Jungbluth A; Jaeger D
J Invest Surg; 2007; 20(3):181-6. PubMed ID: 17613693
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].
Yang QC; Ji XH; Shen Y; Han F; Zhang XJ; Liu HB
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):6-10. PubMed ID: 15796874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
